Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2016 1
2017 1
2020 4
2021 4
2022 1
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Comments on the 2019 ESC guidelines on chronic coronary syndromes.
SEC Working Group for the 2019 ESC guidelines on chronic coronary syndromes, Expert Reviewers for the 2019 ESC guidelines on chronic coronary syndromes, SEC Guidelines Committe; SEC Working Group for the 2019 ESC guidelines on chronic coronary syndromes; SEC Guidelines Committee. SEC Working Group for the 2019 ESC guidelines on chronic coronary syndromes, Expert Reviewers for the 2019 ESC guidelines on chronic coronary syndromes, SEC Guidelines Committe, et al. Rev Esp Cardiol (Engl Ed). 2020 Jun;73(6):439-444. doi: 10.1016/j.rec.2019.12.023. Epub 2020 May 4. Rev Esp Cardiol (Engl Ed). 2020. PMID: 32376227 English, Spanish. No abstract available.
Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Bonanad C, García-Blas S, Torres Llergo J, Fernández-Olmo R, Díez-Villanueva P, Ariza-Solé A, Martínez-Sellés M, Raposeiras S, Ayesta A, Bertomeu-González V, Tarazona Santabalbina F, Facila L, Vivas D, Gabaldón-Pérez A, Bodi V, Nuñez J, Cordero A. Bonanad C, et al. Among authors: torres llergo j. J Clin Med. 2021 Nov 12;10(22):5268. doi: 10.3390/jcm10225268. J Clin Med. 2021. PMID: 34830548 Free PMC article. Review.
Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials.
Cordero A, Nuñez J, Bertomeu-González V, Fácila L, Quintanilla MA, Rodríguez-Mañero M, Escribano D, Valle A, de la Espriella R, Torres-Llergo J, Bayés-Genís A, González-Juanatey JR. Cordero A, et al. Among authors: torres llergo j. Am J Ther. 2022 Sep-Oct 01;29(5):e572-e575. doi: 10.1097/MJT.0000000000001503. Am J Ther. 2022. PMID: 36074989 No abstract available.
Clinical outcomes and mortality in patients with atrial fibrillation and recently diagnosed lung cancer in oncology outpatient settings.
Piserra López-Fernández De Heredia A, Ruiz Ortiz M, Pérez Cabeza AI, Díaz Expósito A, Fernández Valenzuela MI, Carrillo Bailén M, Alarcón De La Lastra Cubiles I, Moreno Vega A, Zalabardo Aguilar M, Chaparro Muñoz M, García Manrique T, Torres Llergo J, Ortega Granados AL, Sánchez Fernández JJ, Calvete Cadenas J, Mesa Rubio D; Working Groups of Atrial Fibrillation and Cardio-Onco-Hematology of the Andalusian Society of Cardiology. Piserra López-Fernández De Heredia A, et al. Among authors: torres llergo j. Curr Probl Cardiol. 2024 Feb;49(2):102239. doi: 10.1016/j.cpcardiol.2023.102239. Epub 2023 Dec 5. Curr Probl Cardiol. 2024. PMID: 38056515 Review.
Lipoprotein(a) and Long-Term Recurrent Infarction After an Acute Myocardial Infarction.
Miñana G, Cordero A, Fácila L, Company M, Fernández-Cisnal A, Valero E, Carratalá A, Navarro J, Llergo JT, Fernández-Olmo R, Castro A, Bodi V, Sanchis J, Núñez J. Miñana G, et al. Among authors: llergo jt. Am J Cardiol. 2024 Jan 15;211:9-16. doi: 10.1016/j.amjcard.2023.10.028. Epub 2023 Oct 18. Am J Cardiol. 2024. PMID: 37858663
Resolution of left ventricular thrombus by rivaroxaban.
Padilla Pérez M, Salas Bravo D, Garcelán Trigo JA, Vazquez Ruiz de Castroviejo E, Torres Llergo J, Lozano Cabezas C, Fernández Guerrero JC. Padilla Pérez M, et al. Among authors: torres llergo j. Future Cardiol. 2014 May;10(3):333-6. doi: 10.2217/fca.14.12. Future Cardiol. 2014. PMID: 24976470
Differences in the prevalence of complex aortic atheromatosis by type of stroke.
Torres-Llergo J, Fernández-Olmo MR, Lozano-Cabezas C, Vázquez-Ruiz de Castroviejo E, Padilla-Pérez M, Fernández-Guerrero JC. Torres-Llergo J, et al. Rev Esp Cardiol (Engl Ed). 2014 Apr;67(4):325-7. doi: 10.1016/j.rec.2013.10.009. Epub 2014 Feb 8. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24774599 No abstract available.
SGLT2 inhibitors and GLP1 agonists administered without metformin compared to other glucose-lowering drugs in patients with type 2 diabetes mellitus to prevent cardiovascular events: A systematic review.
Escobar C, Barrios V, Cosín J, Gámez Martínez JM, Huelmos Rodrigo AI, Ortíz Cortés C, Torres Llergo J, Requeijo C, Solà I, Martínez Zapata MJ. Escobar C, et al. Among authors: torres llergo j. Diabet Med. 2021 Mar;38(3):e14502. doi: 10.1111/dme.14502. Epub 2021 Jan 4. Diabet Med. 2021. PMID: 33368612
Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction.
Esteban-Fernández A, Gómez-Otero I, López-Fernández S, Santamarta MR, Pastor-Pérez FJ, Fluvià-Brugués P, Pérez-Rivera JÁ, López López A, García-Pinilla JM, Palomas JLB, Bonet LA, Cobo-Marcos M, Mateo VM, Llergo JT, Fernández VA, Vives CG, de Juan Bagudá J, Benedicto AM, de Polavieja JIM, Solla-Ruiz I, Solé-González E, Cardona M, Olaetxea JR, Cortés CO, Dosantos VM, López AG, Amao E, Sánchez BC, Torres EA, Carrillo VG, García-Fuertes D, Ridocci-Soriano F; TIDY-HF investigators. Esteban-Fernández A, et al. Among authors: llergo jt. Clin Res Cardiol. 2023 Jun 21. doi: 10.1007/s00392-023-02241-0. Online ahead of print. Clin Res Cardiol. 2023. PMID: 37341769
16 results